Visualitza per autoria "Saiz-Ruiz, Jerónimo"

Ordena per: Ordre: Resultats:

  • A Pharmacovigilance study in first episode of psychosis: psychopharmacological interventions and safety profiles in the PEPs Project.
    Bioque, Miquel; Llerena, Adrián; Cabrera, Bibiana; Mezquida, Gisela; Lobo, Antonio; González-Pinto, Ana; Díaz-Caneja, Covadonga M.; Corripio, Iluminada; Aguilar, Eduardo J.; Bulbena Vilarrasa, Antonio; Castro-Fornieles, Josefina; Vieta, Eduard; Lafuente, Amàlia; Mas, Sergi; Parellada, Mara; Saiz-Ruiz, Jerónimo; Cuesta, Manuel J.; Bernardo, Miquel; PEPs Group (Oxford University Press, 2016)
    BACKGROUND: The characterization of the first episode of psychosis and how it should be treated are principal issues in actual research. Realistic, naturalistic studies are necessary to represent the entire population of ...
  • Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial
    Pérez Solá, Victor; Salavert, Ariana; Espadaler, Jordi; Tusón, Miquel; Saiz-Ruiz, Jerónimo; Sáez-Navarro, Cristina; Bobes, Julio; Baca-García, Enrique; Baca-García, Enrique; Olivares, José M.; Rodriguez-Jimenez, Roberto; Villagrán, José M.; Gascón, Josep; Cañete-Crespillo, Josep; Solé, Montse; Saiz, Pilar A.; Ibáñez, Ángela; Diego-Adeliño, Javier de; AB-GEN Collaborative Group; Menchón, José M. (BioMed Central, 2017)
    BACKGROUND: A 12-week, double-blind, parallel, multi-center randomized controlled trial in 316 adult patients with major depressive disorder (MDD) was conducted to evaluate the effectiveness of pharmacogenetic (PGx) testing ...
  • Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort
    Segura, Àlex G.; Mané Santacana, Anna; Prohens, Llucia; Rodríguez, Natalia; Mezquida, Gisela; Cuesta, Manuel J.; Vieta, Eduard; Amoretti, Silvia; Lobo, Antonio; González-Pinto, Ana; Díaz-Caneja, Covadonga M.; Roldán Bejarano, Alexandra; Jiménez, Esther; Baeza, Immaculada; Legido, Teresa; Saiz-Ruiz, Jerónimo; Bernardo, Miquel; Mas, Sergi; PEPs Group (Elsevier, 2023)
    Cannabis use is highly prevalent in first-episode psychosis (FEP) and plays a critical role in its onset and prognosis, but the genetic underpinnings promoting both conditions are poorly understood. Current treatment ...
  • Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: a longitudinal study in a first episode psychosis cohort
    Segura, Àlex G.; Martínez-Pinteño, Albert; Gassó, Patricia; Rodríguez, Natalia; Bioque, Miquel; Cuesta, Manuel J.; González-Peñas, Javier; García-Rizo, Clemente; Lobo, Antonio; González-Pinto, Ana; García-Alcón, Alicia; Roldán, Alexandra; Vieta, Eduard; Castro-Fornieles, Josefina; Mané Santacana, Anna; Saiz-Ruiz, Jerónimo; Bernardo, Miquel; Mas, Sergi (Elsevier, 2022)
    Objective: metabolic syndrome is a health-threatening condition suffered by approximately one third of schizophrenia patients and largely attributed to antipsychotic medication. Previous evidence reports a common genetic ...

Cerca

Visualitza

El meu compte

Amb col·laboració de Complim Participem